Leaving nothing to chance

suggests that the inherent difficulty of quantifying certain parameters means the only way to understand some biological processes is to replace facts and coherent argument by appealing to randomness.

Written byMike Holcombe
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Arnold Goodman's somewhat defeatist article on the future of central dogma1 suggests that the inherent difficulty of quantifying certain parameters means the only way to understand some biological processes is to replace facts and coherent argument by appealing to randomness.

But the appeal of formal thought cannot be denied. Yuri Lazebnik once wrote that "it is only a question of time before a user-friendly and flexible formal language will be taught to biology students, as it is taught to engineers, as a basic requirement for their future studies."2 This is exactly what we have developed here at Sheffield University: A simple formal descriptive language that is both a powerful conceptual tool and an accurate method for quantitatively describing the behavior of biological processes at any level.3 The description is unambiguous and can be implemented or tested by any programmer or mathematician if required. We have successfully applied this approach to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies